Ignite Creation Date:
2025-12-24 @ 12:31 PM
Ignite Modification Date:
2026-01-01 @ 5:29 AM
Study NCT ID:
NCT00919061
Status:
COMPLETED
Last Update Posted:
2016-02-03
First Post:
2009-06-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-08
Start Date Type:
None
Primary Completion Date:
2014-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-03
Completion Date Type:
ACTUAL
First Submit Date:
2009-06-11
First Submit QC Date:
None
Study First Post Date:
2009-06-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-10-19
Results First Submit QC Date:
None
Results First Post Date:
2016-02-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-01-04
Last Update Post Date:
2016-02-03
Last Update Post Date Type:
ESTIMATED